Editor-in-Chief of the Journal of Medical Internet Research or JMIR mHealth and uHealth

Location: Any Location
Job Type: Full-Time
Employer: Journal of Medical Internet Research or JMIR mHealth and uHealth
JMIR Publications invites nominations and applications for the position of Editor-in-Chief (EIC) for the Journal of Medical Internet Research (JMIR) and JMIR mHealth and uHealth (JMU). Both journals are recognized as the leading digital health journals by quality (leading impact factors) and quantity (number of articles published).

In the fall of 2019, the candidate EICs for JMIR and JMU will initially act as deputy editors or co-EICs working closely with Dr Eysenbach on the transition, which may take 6-12 months. Responsibilities

The EICs' primary responsibilities will include:

  • working with a team of editorial board members to shape, lead, and execute the journal’s editorial scope
  • working alongside the publisher (JMIR Publications) to set priorities and objectives for the journal
  • creating and implementing a strategy to strengthen and grow the journal’s operation
  • re-building/refreshing the editorial board by recruiting and selecting editorial board members and active section editors
  • encouraging and soliciting the submission of original high‐quality manuscripts from colleagues and leading researchers
  • overseeing the peer review of journal content

Both positions may also oversee JMIR Research Protocols and/or JMIR Formative Research, which are the sister journals for protocols and early-stage research, respectively.

Qualifications

JMIR Publications are seeking highly regarded, internationally recognized, active biomedical scientists or academic clinicians (PhD, MD, MD/PhD) who are active in the field of digital health, medical informatics, behavioral sciences, or a similar field. The candidates must be passionate about health research and technology, innovation, and health information dissemination.

Candidates must be energetic and innovative leaders, committed to maintaining a high level of integrity while delivering high-quality research quickly and efficiently. The new EIC for both journals is expected to be a thought leader that will drive strategy and innovation in publishing and digital health, foster a community of authors, editors, and reviewers, and solicit high-quality research from leading authors in the field.

Ideally, candidates will be familiar with–and have published in–JMIR journals and have an established track record as an author. In addition, candidates preferably have editorial experience as a journal editor, and/or deputy or associate editor in a biomedical journal with experience in the peer review process and communicating with authors, reviewers, and publishers. The new EIC for both journals must be familiar with reporting standards, ethical guidelines for publishing, and be aware of the current new developments and changes in the publishing environment, such as preprints.

A stipend will be provided in recognition of the time and effort involved in this position. The position will require at least 20% of the time of a full-time position. If a candidate is in an academic or other full-time position, we will require a letter from the current employer to certify that the time is available. The stipend can also be used to fund a part of the candidates' academic salary. Nominations

If you are not personally interested but know someone who would make a good fit, please fill out our nomination form to suggest the names of highly qualified candidates.

Applying

Interested candidates should send the following documents to This email address is being protected from spambots. You need JavaScript enabled to view it. no later than July 31st 2019:

  • a letter of interest stating the journal they are applying for (JMIR or JMU), a description of their vision for the journal, and thoughts on future advancements and innovations
  • a current curriculum vitae
  • a description of any potential conflicts of interest

As this is a remote position, there is no restriction on the location of the applicant. Follow-up interviews will be scheduled with top candidates. Applicants which do not make it for EIC consideration may still be selected as editorial board members.

This email address is being protected from spambots. You need JavaScript enabled to view it.

About

Our goal is to build upon the outstanding foundation built by Dr Eysenbach to continue the legacy of the Journal of Medical Internet Research and its sister journals by publishing cutting-edge new data and breakthrough findings in the rapidly growing field of digital health. JMIR is incredibly proud of the 20-year history behind the journal. As a pioneer in both open access publishing and digital health research, we have innovated editorial processes and have established short turn-around times, high author satisfaction scores, and extensive author support. But, most importantly, we have continued to help leaders in the health technology space to collaborate and disseminate breakthrough ideas and research on emerging technologies and digital health interventions that can ultimately empower people to make informed decisions about their health and live happier and healthier lives. We are looking forward to having new Editors-in-Chief join us on this mission.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Artificial Intelligence: Unexpected Resu…

Artificial intelligence (AI) is on the rise. Until now, AI applications generally have "black box" character: How AI arrives at its results remains hidden. Prof. Dr. Jürgen Bajorath, a cheminformatics...

Printed Robots with Bones, Ligaments, an…

3D printing is advancing rapidly, and the range of materials that can be used has expanded considerably. While the technology was previously limited to fast-curing plastics, it has now been...

AI identifies Non-Smokers at High Risk f…

Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented next week...

Orchestrating the New World of AI in Hea…

Orion Health's UK and Ireland Customer Conference 2023 focused on the future potential and immediate, practical application of AI to healthcare - and gave delegates a first look at the...

Study Reveals Bias in AI Tools when Diag…

Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups, University of Florida researchers found. While artificial intelligence (AI) tools offer...

Researchers Take New AI Approach to Anal…

Researchers at Karolinska Institutet and SciLifeLab in Sweden have combined artificial intelligence (AI) techniques used in satellite imaging and community ecology to interpret large amounts of data from tumour tissue...

Medical AI Tool from UF, NVIDIA gets Hum…

A new artificial intelligence (AI) computer program created by researchers at the University of Florida and NVIDIA can generate doctors' notes so well that two physicians couldn't tell the difference...

Commission Opens Calls to Invest €42 Mil…

Today, the European Commission opened a new set of calls for proposals under the 2023-2024 Work Programmes of the Digital Europe Programme with a focus on advanced digital skills. The calls...

Bayer Championing Advancements in Radiol…

Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline of its investigational contrast agent as well as new innovations in the area of Artificial Intelligence...

MEDICA and COMPAMED: Medical Technology …

13 - 16 November 2023, Düsseldorf, Germany. After four days of business, MEDICA and COMPAMED in Düsseldorf delivered impressive confirmation that they are excellent platforms for the worldwide medical technology business...

AI Predicts Developmental Paths in Prema…

Researchers at UMC Utrecht have developed an AI model to predict long-term outcome in extremely premature babies early in life. The model can identify which infants might face intellectual disability...

AI Paves Way for New Medicines

A team of researchers from LMU, ETH Zurich, and Roche Pharma Research and Early Development (pRED) Basel has used artificial intelligence (AI) to develop an innovative method that predicts the...